×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| ACUTAAS CHEMICALS LIMITED | 2231.75 | 440.11 | 2072.37 | 5.41 | 12,032 | 63.6 |
| SANOFI INDIA LTD | 4150.0 | 695.0 | 4063.0 | 30.18 | 11701 | 26.5 |
| Vijaya Diagnostic Centre Limit | 1822.68 | 383.89 | 1748.45 | 3.73 | 11367 | 75.4 |
Ami Organics Limited, with Security Code 543349, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 152.4 | 186.4 | 142.4 | 163.6 | 161.7 | 219.9 | 171.1 | 243.6 | 270.9 | 304.2 |
| Expenses | 121.6 | 145.6 | 117.0 | 145.0 | 138.2 | 179.8 | 144.8 | 195.5 | 204.3 | 220.1 |
| Operating Profit | 30.8 | 40.8 | 25.4 | 18.6 | 23.5 | 40.2 | 26.3 | 48.1 | 66.7 | 84.1 |
| OPM % | 20.21% | 21.9% | 17.82% | 11.38% | 14.55% | 18.26% | 15.37% | 19.76% | 24.6% | 27.65% |
| Other Income | 3.0 | -0.2 | 1.1 | -30.5 | 2.9 | 8.6 | 1.9 | 8.6 | 2.2 | 5.7 |
| Interest | 1.2 | 0.6 | 0.5 | 0.8 | 2.6 | 2.1 | 4.4 | 0.5 | 0.6 | 0.4 |
| Depreciation | 3.1 | 3.4 | 3.4 | 3.4 | 3.5 | 4.4 | 5.6 | 6.2 | 5.7 | 6.6 |
| Profit before tax | 29.6 | 36.6 | 22.5 | 15.7 | 20.3 | 42.3 | 18.2 | 50.0 | 62.5 | 82.9 |
| Tax % | -24.6% | -25.8% | -25.2% | 30.6% | -22.8% | -24.1% | -24.6% | -24.7% | -27.6% | -24% |
| Net Profit | 22.3 | 27.2 | 16.9 | -21.0 | 15.7 | 32.1 | 13.7 | 37.7 | 45.3 | 62.8 |
| EPS in Rs | 3.06 | 3.73 | 2.31 | -2.87 | 2.12 | 4.37 | 1.71 | 4.71 | 11.31 | 0 |
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 186.4 | 142.4 | 172.4 | 166.4 | 225.0 | 176.7 | 246.7 | 275.0 | 308.5 | 207.2 |
| Expenses | 145.5 | 117.2 | 147.5 | 139.9 | 181.8 | 147.2 | 197.8 | 206.3 | 223.5 | 156.3 |
| Operating Profit | 40.9 | 25.2 | 24.8 | 26.5 | 43.2 | 29.5 | 48.9 | 68.7 | 85.0 | 50.9 |
| OPM % | 21.92% | 17.67% | 14.4% | 15.93% | 19.19% | 16.71% | 19.83% | 24.97% | 27.55% | 24.56% |
| Other Income | -0.2 | 1.1 | -30.3 | 3.5 | 1.0 | 1.0 | 8.4 | 1.7 | 5.8 | 15.9 |
| Interest | 0.6 | 0.5 | 0.8 | 2.5 | 2.1 | 4.4 | 0.5 | 0.7 | 0.6 | 0.6 |
| Depreciation | 3.4 | 3.4 | 3.7 | 3.8 | 4.9 | 6.2 | 6.8 | 6.3 | 7.3 | 8.1 |
| Profit before tax | 36.7 | 22.3 | 21.8 | 23.7 | 37.5 | 20.0 | 50.0 | 63.3 | 82.9 | 58.1 |
| Tax % | -25.8% | -25.4% | 71.2% | -24.9% | -31% | 26.4% | 24.9% | 28.2% | -24.3% | 24.2% |
| Net Profit | 27.2 | 16.7 | -17.0 | 17.8 | 25.7 | 14.7 | 37.6 | 45.4 | 62.7 | 44.0 |
| EPS in Rs | 3.73 | 2.29 | -2.33 | 2.42 | 3.42 | 1.83 | 4.69 | 5.67 | 0 | 5.41 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 33% |
| 3 Years: | 24% |
| TTM: | 44% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 41% |
| 3 Years: | 30% |
| TTM: | 170% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 38% |
| 1 Year: | 96% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 33% |
| 3 Years: | 25% |
| TTM: | 40% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 41% |
| 3 Years: | 30% |
| TTM: | 167% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 38% |
| 1 Year: | 96% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|